Intekferon-α response and signal transduction pathway in transitional carcinoma cell lines

Advances in Experimental Medicine and Biology

Volumn 539 A, Issue , 2004, Pages 15-32

  Bandyopadhyay, Sudip K ^a   Rackley, Raymond R ^a   Matin, Surena F ^a   Sadhukhan, Provash C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CELL PROLIFERATION; CONFERENCE PAPER; DNA PROBE; GEL MOBILITY SHIFT ASSAY; GENE INDUCTION; HUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RNA ISOLATION; SIGNAL TRANSDUCTION; TRANSITIONAL CELL CARCINOMA; WESTERN BLOTTING; BLADDER TUMOR; CELL CULTURE; DRUG EFFECT; METABOLISM; PHYSIOLOGY; REVIEW;

ANTINEOPLASTIC AGENTS; CARCINOMA, TRANSITIONAL CELL; HUMANS; INTERFERON-ALPHA; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 3242701360     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (43)

1. Bandyopadhyay SK, Kalvakolanu DVR, Sen GC: Gene induction by interferons: functional complementation between trans-acting factors induced by alpha interferon and gamma interferon. Mol Cell Biol, 10:5055, 1990.
2. Bandyopadhyay SK, Leonard Jr GT, Bandyopadhyay T, Stark GR, Sen GC: Transcriptional induction by double-stranded RNA is mediated by interferon-stimulated response elements without activation of interferon-stimulated gene factor 3. J Biol Chem, 270:19624, 1995.
3. Bluyssen HA, Muzaffar R, Vlieststra RJ, van der Made AC, Leung S, Stark GR, et al: Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses. Proc Natl Acad Sci USA, 12:5645, 1995.
4. Borden EC, Grovemen DS, Nasu T, Reznikoff C, Bryan GT: Antiproliferative activities of interferons against human bladder carcinoma cell lines in vitro. J Urol, 132:800, 1984.
5. Boring CC, Squires TS, Tong T: Cancer statistics. Cancer, 46:7, 1996.
6. Bradford MM: A rapid and sensitive method for the quantisation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 72:248, 1976.
7. Darnell Jr JE, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science, 264:1415, 1994.
8. Deiss LP, Feinstein E, Berissi H, Cohen O, Kimchi A: Identification of a novel serine/threonine kinase and a novel 15-kd protein as potential mediators of the g-interferon-induced cell death. Genes and Dev, 9:15, 1995.
9. DeMaeyer E, DeMaeyer-Guignard J: Interferons and Other Regulatory Cytokines. New York Wiley-Interscience; 1988.
10. Dinney CPN, Bielenberg DR, Perrotte P, Reich R, Eve BY, Bucana CD, et al: Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systematic interferon-α administration. Cancer Res, 58:808, 1998.
11. Fu XY, Schindler C, Improta T, Aebersold R, Darnell Jr JE: The proteins of ISGF-3, the interferon-α-induced transcriptional activator, define a gene family involved in signal transduction. Proc Natl Acad Sci USA, 89:7840, 1992.
12. Giannopoulos A, Constantinides C, Kortsaris A, Chrisofos M, Pavlaki C, Dimopoulos C: Determination of interferon-α receptors in urothelial cancer and in normal urothelium. J Urol, 157:79, 1997.
13. Grander D, Xu B, Einhorn S: Cytotoxic effect of interferon on primary malignant tumor cells. Studies in various malignancies. Eur J Cancer, 14:1940, 1993.
14. Groveman DS, Borden EC, Merritt JA, Robins HI, Steeves R, Bryan GT: Augmented antiproliferative effects of interferons at elevated temperatures against human bladder carcinoma cell lines. Cancer Res, 44:5517, 1984.
15. Gutterman JU: Cytokine therapeutics: Lessons from interferon-α. Proc Natl Acad Sci USA, 91:1198, 1984.
16. Haque SJ, Williams BRG: Identification and characterization of an interferon (IFN)-stimulated response element-IFN-stimulated gene factor 3-independent signaling pathway for IFN-α. J Biol Chem, 269:19523, 1994.
17. Ihle JN, Kerr IM: Kaks and stats in signaling by the cytokine receptor superfamily. Trends Genet, 11:69, 1995.
18. Kaplan DH, Shankaran V, Dighe AS, Stocken E, Aguet M, Old LJ, et al: Demonstration of an interferon-γ-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA, 95:7556, 1998.
19. Kolla V, Lindner DJ, Weihua X, Borden EC, Kalvakolanu DV: Modulation of interferon (IFN)-inducible gene expression by retinoic acid. J Biol Chem 271:10506, 1996.
20. Leung S, Qureshi SA, Kerr IM, Darnell Jr JE, Stark GR: Role of STAT2 in the alpha interferon signaling pathway. Mol Cell Biol, 15:1312, 1995.
21. Levy DE, Raz R, Durbin JE, Bluyssen H, Muzaffar R, Pisharody S: Cytoplasmic transcription factors: mediators of cytokine. Agents Actions Suppl, 47:79, 1995.
22. Morales A, Eidinger D, Bruce AW: Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol, 116:180, 1976.
23. Müller M, Briscoe J, Laxton C, Guschin D, Siemiecki A, Silvenoinen O, et al: The protein tyrosine kinase JAK1 complements defects in interferon-α/β and γ signal transduction. Nature (London), 366:129, 1993.
24. Ostlund L, Grander D, Julliusson G, Robert K-H, Lundgren E, Einhorn S: α-Interferon receptors in malignant B-cells from patients with chronic lymphocytic leukemia: Relation to induction of 2′,5′-oligoadenylate synthetase and blast transformation. Cancer Res, 489:3425, 1989.
25. Petricoin III EF, David M, Fang H, Grimley P, Larner AC, Vande Pol S: Human cancer cell lines express a negative transcriptional regulator of the interferon regulatory factor family of DNA binding proteins. Mol Cell Biol, 14:1477, 1994.
26. Petricoin III EF, Ito S, Williams BL, Audet S, Stancato LF, Gamero A, et al: Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling. Nature, 390:629, 1997.
27. Plantanias LC, Uddin S, Colamonici OR: Tyrosine phosphorylation of the A and B subunits of the type I interferon receptor. J Biol Chem, 269:17761, 1994.
28. Pryor K, Stricker P, Russell P, Golovsky D, Penny R: Antiproliferative effects of bacillus Calmette-Guerin and interferon a2b on human bladder cancer cells in vitro. Cancer Immunol Immunother, 41:309, 1995.
29. Rodriguez-Villanueva J, McDonnell TJ: Induction of apoptotic cell death in non-melanoma skin cancer by interferon-α. Int J Cancer, 61:110, 1995.
30. Sangfelt O, Erickson S, Castro J, Heiden T, Einhorn S, Grander D: Induction of apoptosis and inhibition of cell growth are independent responses to interferon-α in hematopoietic cell line. Cell Growth and Diff, 8:343, 1997.
31. Schindler C, Darnell Jr JE: Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem, 64:621, 1995.
32. Shin MS, Rackley RR, Appell RA, Vasavada SP, Bandyopadhyay SK: Different patterns of signal transduction activation in urothelial cells derived from the ureter versus the bladder: not all urothelium is the same. American Urological Association (Abstract), 1997.
33. Shuai K, Schindler C, Prezioso VR, Darnell Jr JE: Activation of transcription of IFN-γ: tyrosine phosphorylation of a 91-kD DNA binding protein. Science, 258:1808, 1992.
34. Shuai K, Ziemiecki A, Wilks AF, Harpur AG, Sadowski HB, Gilman MZ, et al: Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature (London), 366:580, 1993.
35. Silvennoinen O, Ihle JN, Schlessinger J, Levy DE: Interferon-induced nuclear signalling by Jak protein tyrosine kinases. Nature (London), 366:583, 1993.
36. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD: How cells respond to interferons. Annu Rev Biochem, 67:227, 1998.
37. Torti FM, Lum BL: Superficial bladder cancer. Risk of recurrence and potential role of interferon therapy. Cancer, 59:613, 1987.
38. Torti FM, Shortliffe LD, Williams RD, Pitts WC, Kempson RL, Ross JC, et al: Alpha-interferon in superficial bladder cancer: A Northern California Oncology Group Study. J Clin Oncology, 6:476, 1988.
39. Trubiani O, Bosco D, Di-Primio R: Interferon γ (IFN-γ) induces programmed cell death in differentiated human B-cell lines. Exp Cell Res, 215:23, 1994.
40. Velazquez L, Fellous M, Stark GR, Pellegrini S: A protein tyrosine kinase in the interferon α/β signaling pathway. Cell, 70:313, 1992.
41. Watling D, Guschin D, Müller M, Silvennoinen O, Witthuhn BA, Quelle FW, et al: Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defects in the interferon-γ signal transduction pathway. Nature (London), 366:166, 1993.
42. Wong LH, Krauer KG, Hatzinisiriou I, Estcourt MJ, Hersey P, Tam ND, et al: Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3g. J Biol Chem, 272:28779, 1987.
43. Xu BB, Grander D, Sangfelt O, Einhorn S: Primary leukemia cells resistant to α-interferon in vitro are defective in the activation of the DNA-binding factor interferon-stimulated gene factor 3. Blood, 84:1942, 1994.